Why does this page look this way?
It appears that you are using either an older, classic Web browser or a hand-held device that allows you to view our content but may not work with every feature of our site. If you are using an older browser, please upgrade for the best experience.
Navigation
home > think tank > research projects > Global Health Roundtable Series: “Can U.S. Foreign Aid Support What Works for Global Health?”
| Director: | Laurie A. Garrett, Senior Fellow for Global Health |
|---|
May 2007 - Present
The Series was developed with the Global Public Health Practice at McKinsey & Company.
The goal of the series is to examine proven technologies that are known to be life-saving, but are not yet in widespread use in poor countries. A number of questions will be discussed, including: What are the barriers to ubiquitous use? What controversies surround them? Are there specific funding issues in Congress or in the Executive branch that currently make support for these efforts difficult, or impossible? Are there domestic political issues in the US that limit their application? Are there reasons that desirability of these innovations is limited, on the ground in target countries? Are there novel ways to overcome current barriers to implementation, including different economic models?
A CFR general meeting and four roundtables will take place throughout spring and summer of 2007 where medical technologies such as male circumcision, HPV vaccine, eyeglasses, HIV vaccine, and sterile syringes will be discussed.
Meetings
Closing the Gaps in Latin America in a Time of World Crisis
Related Projects: Global Health Roundtable Series: “Can U.S. Foreign Aid Support What Works for Global Health?”, Globalization and Democracy in Latin America Roundtable Series
| Speaker: | Julio Frenk Mora, Harvard School of Public Health |
|---|---|
| Presiders: | Laurie A. Garrett, Council on Foreign Relations |
| Shannon K. O'Neil, Council on Foreign Relations |
Global Health Roundtable Series: Japan and the G8
Related Project: Global Health Roundtable Series: “Can U.S. Foreign Aid Support What Works for Global Health?”
| Presider: | Laurie A. Garrett, Senior Fellow for Global Health, Council on Foreign Relations |
|---|---|
| Speaker: | Keizo Takemi, Vice Health Minister, Ministry of Foreign Affairs, Japan |
Global Health Roundtable Series: How to Broaden the Availabilty of Eyeglasses Worldwide
Related Project: Global Health Roundtable Series: “Can U.S. Foreign Aid Support What Works for Global Health?”
| Presiders: | Laurie A. Garrett, Senior Fellow for Global Health, Council on Foreign Relations |
|---|---|
| Jordan S. Kassalow, Co-founder & Chairman, Scojo Foundation | |
| Liliana Riva-Clement, Manager, USAID Child Blindness Program | |
| Speakers: | Leon Ellwein, Associate Director, National Eye Institute, National Institutes of Health |
| Kevin Frick, Professor, Johns Hopkins Bloomberg School of Public Health | |
| Bruce Moore, Chair, Department of Specialty and Advanced Clinical Care, New England College of Optometry | |
| Frank Baynham, Chairman of the Board, Gift of Sight, Executive Vice President, Luxottica | |
| Jordan S. Kassalow, Co-founder & Chairman, Scojo Foundation | |
| Kathy Spahn, President and Chief Executive Officer, Helen Keller International | |
| Anthony Walton, Vice Chairman, Americas, Standard Chartered Bank | |
| Andrew Fisher, Executive Director, Lavelle Fund for the Blind | |
| Michael Zeilinger, Chief, Nutrition Division, U.S. Agency for International Development |
Report summary by Kammerle Schneider
When Progress is Incremental: Implications of a Partial Efficacy HIV Vaccine for U.S. Foreign Policy
Related Project: Global Health Roundtable Series: “Can U.S. Foreign Aid Support What Works for Global Health?”
| Presider: | Laurie A. Garrett, Senior Fellow for Global Health, Council on Foreign Relations |
|---|---|
| Speakers: | Seth F. Berkley, President & CEO, International AIDS Vaccine Initiative |
| Michael Robertson, Merck & Co., Inc. | |
| Mitchell Warren, Executive Director, AIDS Vaccine Advocacy Coalition |
Report summary by Kammerle Schneider
When a Sharp Reduction of Economic Burden is within Reach: How Should U.S. Foreign Policy Address the Challenge of Sterile Syringes?
Related Project: Global Health Roundtable Series: “Can U.S. Foreign Aid Support What Works for Global Health?”
| Presider: | Laurie A. Garrett, Senior Fellow for Global Health, The Council on Foreign Relations |
|---|---|
| Speakers: | Gary M. Cohen, Executive Vice President, Becton, Dickinson & Company |
| Michael J. Free, Vice President, Senior Advisor for Technologies, Program for Appropriate Technology in Health (PATH) | |
| Renuka Gadde, Director, Global Health, Becton, Dickinson & Company | |
| Ahmed E. Gomaa, Senior Medical Officer and Chief of National Surveillance Team, Centers for Disease Control & Prevention | |
| Edward Hoekstra, Senior Health Advisor Global Measles Programme & Health Emergencies, United Nations Children's Fund (UNICEF) |
Report summary by Kammerle Schneider
Global Health Roundtable Series: “Can U.S. Foreign Aid Support What Works for Global Health?” - HPV
Related Project: Global Health Roundtable Series: “Can U.S. Foreign Aid Support What Works for Global Health?”
| Presider: | Laurie A. Garrett, Senior Fellow for Global Health, The Council on Foreign Relations |
|---|---|
| Speakers: | Judith Bruce, Senior Associate for Poverty, Gender, and Youth, The Population Council |
| Mark Feinberg, Vice President of Medical Affairs and Policy, Merck | |
| Diane M. Harper, Professor, Director of the Gynecologic Cancer Prevention Research Group, Norris Cotton Cancer Center at Dartmouth Medical School | |
| Rob Hecht, Senior Vice President of Public Policy, International AIDS Vaccine Initiative (IAVI) | |
| Mark Kane, Former Director of the Children's Vaccine Program, PATH | |
| Deborah E. Myers, Director, External and Government Affairs and Public Partnerships, GlaxoSmithKline Biologicals | |
| Anne Schuchat, Assistant Surgeon General, Director, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention | |
| Anne Schuind, Director, Clinical R & D and Medical Affairs, Vaccines, GlaxoSmithKline | |
| Roberto Tapia, Former Vice Secretary of Health, Mexico |
Session 1: HPV Vaccine Efficacy and Manufacturer Responsibility
Session 2: Challenges and Opportunities for HPV Roll-out
Session 3: Donor and Stakeholder Involvement: U.S. Policy and International Financing Update
Conquering Cancer one Poke at a Time: Can the HPV Vaccine Eliminate Cervical Cancer Worldwide? - By Sheri Fink
Is Male Circumcision the Key to Stopping the AIDS Epidemic?
Related Project: Global Health Roundtable Series: “Can U.S. Foreign Aid Support What Works for Global Health?”
| Speakers: | Mark R. Dybul, U.S. Global AIDS Coordinator, U.S. Department of State |
|---|---|
| Thomas R. Frieden, Commissioner, New York City Department of Health and Mental Hygiene | |
| Presider: | Laurie A. Garrett, Senior Fellow for Global Health, Council on Foreign Relations |
Is Male Circumcision the Key to Stopping the AIDS Epidemic? By Sheri Fink, MD, Harvard School of Public Health
This meeting is on the record.
Explore the international finance regime with a new interactive from CFR's program on International Institutions and Global Governance.
Identifying international threats and acting on them may be the most difficult job for U.S. policymakers. This report
provides an actionable road map for managing international threats before they erupt into crises and makes a strong case that preventive action is not a luxury but a necessity.
For more than a decade, the United States has mostly watched from the sidelines as Asian countries organize themselves into an alphabet soup of new multilateral groups. In this report, the authors review the relationship between pan-Asian and trans-Pacific institutions and suggest policy guidelines for a new U.S. approach to this new Asian landscape.
Complete list of Council Special Reports
Start-Up Nation addresses the trillion-dollar question: How is it that Israel—a country of 7.1 million, only sixty years old, surrounded by enemies— produces more start-up companies than large, peaceful, and stable nations like Japan, China, India, Korea, Canada, and the UK? With the insights of geopolitical experts and investors, the authors examine this nation’s adversity-driven culture to answer this question and offer prescriptions for a global economy on the rebound.
In Forces of Fortune, Vali Nasr presents a paradigm-changing revelation that will transform the understanding of the Muslim world at large. He reveals that there is a vital but unseen rising force in the Islamic world—a new business-minded middle class—that is building a vibrant new Muslim world economy and that holds the key to winning the cold war against Iran and extremists.
In Cuba: What Everyone Needs to Know, Julia E. Sweig presents a remarkably accessible portrait of Cuba's unique place on the world stage over the past fifty years, including its internal politics, its often fraught relationship with the United States, and its shifting relationship with the global community.
Complete list of CFR Books
For more information on the David Rockefeller Studies Program, contact:
James M. Lindsay
Senior Vice President, Director of Studies, and Maurice R. Greenberg Chair
+1.212.434.9626 (NY); +1.202.509.8405 (DC)
jlindsay@cfr.org
Janine Hill
Deputy Director of Studies Administration
+1.212.434.9753
jhill@cfr.org
Browse Content By Region IssuePublication TypeThe Think TankFor The MediaFor Educators About CFR
Copyright 2009 by the Council on Foreign Relations. All Rights Reserved.
